Z-338
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Functioanl Dyspepsia
Conditions
Functioanl Dyspepsia
Trial Timeline
Apr 1, 2007 → Jul 1, 2010
NCT ID
NCT00458328About Z-338
Z-338 is a phase 2 stage product being developed by Zeria Pharmaceutical for Functioanl Dyspepsia. The current trial status is completed. This product is registered under clinical trial identifier NCT00458328. Target conditions include Functioanl Dyspepsia.
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01973790 | Phase 3 | Completed |
| NCT00458328 | Phase 2 | Completed |
| NCT00333372 | Phase 2 | Completed |
| NCT00323817 | Phase 2 | Completed |
| NCT00298194 | Phase 2 | Completed |